WO1999019491A3 - Human dnax interleukin-40 (dil-40) - Google Patents
Human dnax interleukin-40 (dil-40) Download PDFInfo
- Publication number
- WO1999019491A3 WO1999019491A3 PCT/US1998/020932 US9820932W WO9919491A3 WO 1999019491 A3 WO1999019491 A3 WO 1999019491A3 US 9820932 W US9820932 W US 9820932W WO 9919491 A3 WO9919491 A3 WO 9919491A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dil
- human dnax
- interleukin
- dnax interleukin
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU97863/98A AU9786398A (en) | 1997-10-14 | 1998-10-13 | Human dnax interleukin-40 (dil-40) |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95023897A | 1997-10-14 | 1997-10-14 | |
| US08/950,238 | 1997-10-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1999019491A2 WO1999019491A2 (en) | 1999-04-22 |
| WO1999019491A3 true WO1999019491A3 (en) | 1999-07-01 |
Family
ID=25490146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/020932 Ceased WO1999019491A2 (en) | 1997-10-14 | 1998-10-13 | Human dnax interleukin-40 (dil-40) |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR016145A1 (en) |
| AU (1) | AU9786398A (en) |
| WO (1) | WO1999019491A2 (en) |
| ZA (1) | ZA989343B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7148330B2 (en) | 1999-07-30 | 2006-12-12 | Schering Corporation | Binding compounds for IL-27 |
| WO2001009176A2 (en) * | 1999-07-30 | 2001-02-08 | Schering Corporation | Mammalian cytokines; related reagents |
| WO2009118371A1 (en) | 2008-03-28 | 2009-10-01 | Janssen Pharmaceutica Nv | Use of nicotinamide for treating summer itch in horses |
-
1998
- 1998-10-13 AR ARP980105096A patent/AR016145A1/en unknown
- 1998-10-13 WO PCT/US1998/020932 patent/WO1999019491A2/en not_active Ceased
- 1998-10-13 ZA ZA9809343A patent/ZA989343B/en unknown
- 1998-10-13 AU AU97863/98A patent/AU9786398A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| N.Y. IP ET AL: "The neurotrophins and CNTF: Two families of collaborative neurotrophic factors", ANNUAL REVIEW OF NEUROSCIENCE, vol. 19, 1996, pages 491 - 515, XP002096172 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999019491A2 (en) | 1999-04-22 |
| AU9786398A (en) | 1999-05-03 |
| ZA989343B (en) | 2000-04-13 |
| AR016145A1 (en) | 2001-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2100959A3 (en) | Mammalian cytokine: interleukin-B30 and related reagents | |
| WO1995018826A3 (en) | Purified primate ctla-8 antigens and related reagents | |
| WO1998027114A3 (en) | Mammalian cell surface antigens; related reagents | |
| CA2263129A1 (en) | Mammalian cell surface antigens; related reagents | |
| WO1997021812A3 (en) | Mammalian chemokine ccf8 and chemokine receptor cckr3 | |
| EP1897949A3 (en) | Human interleukin-B50. Therapeutic uses | |
| LU91756I2 (en) | denosumab | |
| EP1942114A3 (en) | Mammalian cytokines; related reagents and methods | |
| WO1998001557A3 (en) | Mammalian chemokine reagents | |
| WO2000042188A3 (en) | Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses | |
| WO1998024906A3 (en) | Isolated mammalian monocyte cell genes; related reagents | |
| WO1998011226A3 (en) | Mammalian chemokines, related reagents | |
| AU1825097A (en) | Mammalian cx3c chemokine genes | |
| WO1999003993A3 (en) | Suppressors of cytokine signaling; related reagents | |
| WO1998023750A3 (en) | Mammalian chemokines | |
| WO1998039421A3 (en) | Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents | |
| WO1998032858A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
| WO2003020005A3 (en) | Lp mammalian proteins; related reagents | |
| WO2002068596A3 (en) | Mammalian cytokines; related reagents | |
| DE69534178D1 (en) | S?ugetier thymokingene | |
| WO1998031810A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
| WO1999019491A3 (en) | Human dnax interleukin-40 (dil-40) | |
| WO1999047673A3 (en) | Isolated mammalian membrane protein genes and related reagents | |
| WO2002074906A3 (en) | Lp mammalian proteins; related reagents | |
| WO2001009176A3 (en) | Mammalian cytokines; related reagents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GD GE HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CN CZ EE GD GE HR HU ID IL IS JP KG KR KZ LC LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK SL TJ TM TR TT UA UZ VN YU |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |